Site Search
Search Results
Health Care Providers Call on Governor Hochul to Sign Biomarker Testing Bill without Delay
LAKE SUCCESS, NY – November 27, 2023 – Local health care providers, cancer survivors, and patient advocates gathered today at the Northwell Health Cancer Institute to call on Governor Kathy Hochul to prioritize health equity by improving access to biomarker testing and signing Senate ...
Legislation Aimed at Improving Health Outcomes for New Yorkers Awaits Governor's Action
... more cancer patients can get the testing needed to access precision medicine. Biomarker testing has become a game-changing part of cancer care given its role in opening the door to targeted treatments that can lead to improved survivorship and quality of life. Despite the proven ... obstacles to cancer prevention, detection, treatment and survival, improving access to biomarker testing can extend lives and help advance health equity in precision medicine . Despite evidence demonstrating the effectiveness of biomarker testing and targeted therapy, currently not all ... insurance plans, including Medicaid, will ensure that these new treatments are accessible for more New Yorkers, potentially reducing health disparities and improving outcomes for patients.” In addition to the bill receiving bipartisan support, Eric Linzer, President and CEO ...
Steps Governor Hochul Can Take to Make New York a Leader in Health Equity
... breakthroughs in research and treatment, but there is still a lot of work to be done. If New York aims to remain a national leader in cancer care, as I believe the Empire State is meant to be, our elected officials must be champions in the fight to achieve health equity for all communities. From the inception of Medicare to the expansion of Medicaid, health equity has been the throughline for policies that improve health outcomes and address morbidity and mortality rates. There is plenty of ...
Legislation Aimed at Improving Health Outcomes for New Yorkers Heads to Governor Hochul’s Desk
... desk, giving her 10 days to take action on the legislation. Their proposal aims to ensure millions of New Yorkers can access precision care by requiring all state-regulated health plans to cover comprehensive biomarker testing. Biomarker testing opens the door to treatments that can lead to fewer side effects, improved ... Hochul will sign the legislation without any amendments to limit its benefits to patients. There is strong consensus among medical and public health leaders across New York that biomarker testing is an increasingly critical asset in cancer care and the treatment of other diseases. The ...
Governor Hochul Signs Game-Changing Legislation Aimed at Improving Health Outcomes, Quality of Life for New Yorkers
... Bill 1196a / Assembly Bill 1673a into law, securing a major win for patients across New York. The new law will require all state-regulated health plans, including Medicaid, to cover comprehensive biomarker testing, which will enable more New Yorkers to access precision medicine ... lower costs for patients facing cancer and other serious illnesses. “ACS CAN is proud to see New York, a longstanding leader in health equity and medical innovation, join thirteen other states that have recently enacted similar legislation,” said Lisa Lacasse, President ... treatments, giving patients a better chance of living longer, healthier lives.” Biomarker testing has become a game-changing part of cancer care given its role in opening the door to personalized care, including targeted treatments that can lead to improved survivorship and quality of ...
Calls to Improve New Yorkers’ Access to Precision Medicine Through Biomarker Testing Bring Together Patients and Providers from across Disease Spectrum
ALBANY, NY – APRIL 19, 2023 – With budget talks nearing an end, key public health, patient and provider groups have launched a campaign to urge New York lawmakers to support Assembly Bill 1673 / Senate Bill 1196. The proposed legislation seeks to improve New Yorkers’ access to precision medicine, requiring all state-regulated health plans, including Medicaid, to cover biomarker testing when it is supported by medical and scientific evidence. Over 60 organizations have ... time. Utilizing information from patients’ own genes and tissue, biomarker testing unlocks the door to precision medicine, or personalized care. Biomarker testing helps providers to identify the most appropriate treatment for a disease. In cancer care, this can enable patients to ...
**MEDIA ADVISORY – RALLY **
... Bill 1196 / Assembly Bill 1673 and how access to biomarker testing plays a role in the fight to end all suffering and death from cancer and the health inequities that permeate cancer care. Additional cancer survivors—some of whom have benefitted from biomarker testing—will be in attendance and available for interviews to speak about how biomarker testing factors into cancer care and health equity. ### About ACS CAN The American Cancer Society Cancer Action Network (ACS CAN) makes cancer a top priority for policymakers at ...
Cancer Survivors Rally for New Yorkers’ Access to Precision Medicine, Urge Governor Hochul to Sign Biomarker Testing Bill
BUFFALO, NY – November 8, 2023 – Earlier today, cancer survivors gathered at Buffalo’s City Hall alongside health care providers and patient advocates to emphasize the importance of biomarker testing for the health of New York State, its people and its potential for an equitable, hope-filled future. Attendees of the rally called on Governor Hochul to ...
Patient Advocates Rally in Times Square for New Yorkers’ Access to Precision Medicine, Urge Governor Hochul to Sign Biomarker Testing Legislation
NEW YORK, NY – November 16, 2023 – Earlier today, cancer survivors gathered in Times Square alongside health care providers and patient advocates to emphasize the importance of biomarker testing for the health of New York State, its people and its potential for an equitable, hope-filled future. Attendees of the rally called on Governor Hochul to ...
Lawmakers can improve the odds in New Yorkers' battles against cancer
... received the three lifechanging words “you have cancer” and around 32,230 died from the disease. Innovation in early detection and cancer care are changing how we detect and treat cancer, but these staggering incidence and mortality rates suggest that many New Yorkers aren’t ... increasingly important for the treatment of other diseases, including arthritis, other autoimmune conditions and rare diseases. Currently, many health insurance plans in New York, including Medicaid, may not cover the most appropriate biomarker testing for all patients who could benefit, ... tested for certain guideline-indicated biomarkers. With biomarker testing increasingly becoming a standard of care in oncology, it’s time that health insurance plans keep up with innovations in testing and treatment. Improving access to biomarker is a simple way for legislators in Albany ...